X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

期刊標題檢索 INT J IMMUNOPAT 最新評論: Review speed: 6.0 | Submission acceptance rate: 50.0 Experience shar... (2023-11-01)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY]您好,您是該頁面的第 5336 位訪客。

期刊簡介
期刊名稱INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
LetPub Score
3.4
50 ratings
Rate

Reputation
2.2

Influence
3.6

Speed
7.0

期刊簡稱INT J IMMUNOPATH PH
ISSN2058-7384
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
4.000.6110.581
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmacology
Q3174 / 313
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology and Allergy
Q3141 / 233
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Immunology
Q3156 / 236

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
International Journal of Immunopathology and Pharmacology is an Open Access peer-reviewed journal publishing original papers describing research in the fields of immunology, pathology and pharmacology. The intention is that the journal should reflect both the experimental and clinical aspects of immunology as well as advances in the understanding of the pathology and pharmacology of the immune system.
官方網站https://journals.sagepub.com/home/iji
在線稿件提交http://www.sagepub.com/journals/Journal202411#submission-guidelines
開放訪問Yes
出版商SAGE Publications Inc.
主題領域Immunology and Microbiology
出版國/地區Italy
發行頻率
創刊年0
每年文章數77每年文章數趨勢
黃金OA百分比93.42%
OA Related Info
APC: Yes( USD2650; )
APC waiver:Check Notes
Other charges: No
Keywords: immunology、pathology、pharmacology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ3105/181
PATHOLOGYSCIEQ227/88
PHARMACOLOGY & PHARMACYSCIEQ2136/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2058-7384%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 15 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Science ImmunologyH-index: 0

    CiteScore: 32.90
    Journal of Allergy and Clinical Immunology-In PracticeH-index: 40

    CiteScore: 11.10
    Cancer Immunology ResearchH-index: 62

    CiteScore: 15.60
    npj VaccinesH-index: 8

    CiteScore: 11.90
    OncoImmunologyH-index: 58

    CiteScore: 12.80
    OncoImmunologyH-index: 49

    CiteScore: 12.80
    ALLERGOLOGY INTERNATIONALH-index: 45

    CiteScore: 12.60
    HLAH-index: 93

    CiteScore: 3.00
    Immunity & AgeingH-index: 38

    CiteScore: 10.20
    Clinical and Translational AllergyH-index: 28

    CiteScore: 7.50
    學科內最受檢索的期刊 頁面查看次數
    Journal of Inflammation Research74011
    Cancer Immunology Research57115
    OncoImmunology54833
    OncoImmunology50227
    Science Immunology39880
    npj Vaccines29236
    Human Vaccines & Immunotherapeutics24487
    Human Vaccines & Immunotherapeutics24461
    Endocrine Metabolic & Immune Disorders-Drug Targets20787
    Journal of Allergy and Clinical Immunology-In Practice18714
  •  

    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY] 的評論撰寫評論
作者: 努力啊大罗敷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-01 12:02:44 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0 Experience sharing: 5.9 After submitting, it took 11.1 days to receive the first review result, which was a rejection with only two short sentences of feedback. I followed up in July and August, but was told both times that my submission was still being processed. I almost forgot about this article. Regardless of whether it is accepted or not, the speed of this process is really excessive
(0) 讚! | 努力啊大罗敷

作者: 削月香利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-16 15:58:28 評論於
How long is the external audit cycle?
(0) 讚! | 削月香利

作者: 蓉沼心霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-27 19:39:10 評論於
Hello, how are you doing? #Journal Forum#
(0) 讚! | 蓉沼心霞

作者: Byron Eddie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-02 09:15:17 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Research focus: Inflammation; Pancreas
Experience sharing: Pancreatitis-induced lung injury 0046
(0) 讚! | Byron Eddie

作者: 柯言公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-23 19:40:30 評論於
This is also the third time I've looked for a reviewer, I don't know why
(0) 讚! | 柯言公子

作者: 柯言公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-23 17:15:51 評論於
I usually review and edit for about 10 days before submitting for external review
(0) 讚! | 柯言公子

作者: Judith Hobbes


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-08 16:12:30 評論於
Hello, is it normal for an Editor assessment to take half a month?
(0) 讚! | Judith Hobbes

作者: Judith Hobbes


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-02-08 13:34:27 評論於
Hello, has it been normal for half a month since the Editor assessment?
(0) 讚! | Judith Hobbes

作者: 藤原秋之


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-19 11:27:40 評論於
Review speed: 3.0 | Submission hit rate: 50.0 Heavy research direction: Asthma Experience sharing: Already looking for reviewers for the third time, so strange why
(0) 讚! | 藤原秋之

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 11:49:27 評論於
Most journals require submissions in Word format, but some also accept submissions in PDF format
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 09:00:22 評論於
Most journals use online submission for their articles. Authors need to prepare their manuscript, figures, and other supplementary data in advance. The submission process usually involves visiting the journal's official website, opening the "submit paper" section, registering an account as the corresponding author, logging in as an author, following the prompts to complete the submission, downloading the PDF file, ensuring accuracy, and finally submitting the manuscript
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 13:14:14 評論於
Should I upload the article in Word or PDF?
(0) 讚! | 陶宜三岁啦

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 13:03:11 評論於
How should articles be uploaded?
(0) 讚! | 八坂篷蔚

作者: 气甲爱欢


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-08-06 23:42:39 評論於
Heavy research direction: Tumor
Experience sharing: After acceptance, it has been delayed for a year and has not been published online yet. Emailed the journal but never received a response. It's too bad, preparing to withdraw the submission
(0) 讚! | 气甲爱欢

作者: 拂柳晏静


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-09-17 11:43:51 評論於
Is this SCI?
(0) 讚! | 拂柳晏静

作者: 太山乐蓝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-10-19 13:44:36 評論於
Review speed: 3.0
Experience sharing: The first review took 2 and a half months, it has been revised, I don't know how long the second review will take?
(0) 讚! | 太山乐蓝

作者: Boyd Larkin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-07-17 12:28:11 評論於
Review Speed: 3.0
Sharing Experience: Already deleted, not sure if medline still counts
(0) 讚! | Boyd Larkin

作者: Boyd Larkin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-06-17 20:19:08 評論於
Editorial speed: 3.0 Experience sharing: Got kicked by SCI
(0) 讚! | Boyd Larkin

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-11-28 16:26:26 評論於
Can we reach 3 points next year? Let's discuss
(0) 讚! | 凌霄高洁

作者: 白云运良


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2012-06-21 12:49:27 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0
Sharing Experience: This journal has a three-month cycle, and one of my submissions was accepted
(0) 讚! | 白云运良

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*